These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3335884)

  • 41. Comparison of community and referral intensive care unit patients in a tertiary medical center: evidence for referral bias in the critically ill.
    Seferian EG; Afessa B; Gajic O; Keegan MT; Hubmayr RD;
    Crit Care Med; 2008 Oct; 36(10):2779-86. PubMed ID: 18828201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis.
    Carter A; Humphreys L; Snowdon N; Sharrack B; Daley A; Petty J; Woodroofe N; Saxton J
    Trials; 2015 Oct; 16():468. PubMed ID: 26470880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unfavorable outcome of pediatric onset multiple sclerosis: Follow-up in the pediatric and adult neurology departments of one referral center, in Turkey.
    Derle E; Kurne AT; Konuşkan B; Karabudak R; Anlar B
    Mult Scler Relat Disord; 2016 Sep; 9():1-4. PubMed ID: 27645334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The characteristics of a national register of people with multiple sclerosis (MS): a comparison between the ARMS (Action for Research into Multiple Sclerosis) register and 10 British MS populations.
    Monks J; Robinson I
    J Epidemiol Community Health; 1989 Jun; 43(2):179-86. PubMed ID: 2592908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of the international classification of functioning, disability and health to describe patient-reported disability: a comparison of motor neurone disease, Guillain-Barré syndrome and multiple sclerosis in an Australian cohort.
    Ng L; Khan F
    Disabil Rehabil; 2012; 34(4):295-303. PubMed ID: 21988084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The 8-Year Experience of the Florence Referral ECMO Center and Retrieval Team for Acute Respiratory Failure.
    Cianchi G; Lazzeri C; Bonizzoli M; Batacchi S; Cozzolino M; Ciapetti M; Bernardo P; Franci A; Chiostri M; Peris A
    J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1142-1150. PubMed ID: 29079016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paraclinical support of the person diagnosed with multiple sclerosis.
    Vitali S
    Int MS J; 2004 Apr; 11(1):2-9. PubMed ID: 15125811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Timed instrumental activities of daily living in multiple sclerosis: The test of everyday cognitive ability (TECA).
    Charvet LE; Shaw MT; Sherman K; Haas S; Krupp LB
    Mult Scler Relat Disord; 2018 Jul; 23():69-73. PubMed ID: 29778936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Employment and absenteeism in working-age persons with multiple sclerosis.
    Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
    J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A tangled web: don't miss multiple sclerosis.
    Burdett SK
    Adv Nurse Pract; 2005 Nov; 13(11):51-3, 56. PubMed ID: 16295004
    [No Abstract]   [Full Text] [Related]  

  • 51. Inverse Relation between MxA Gene Expression and Age in Multiple Sclerosis Patients Reveals a Gender Difference in Response to Interferon Therapy.
    Taheri M; Mirinezhad M; Omrani MD; Sajjadi E; Inoko H; Sayad A
    Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):21-27. PubMed ID: 28417621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural history of multiple sclerosis: risk factors and prognostic indicators.
    Vukusic S; Confavreux C
    Curr Opin Neurol; 2007 Jun; 20(3):269-74. PubMed ID: 17495619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No relevant impact of ambient temperature on disability measurements in a large cohort of patients with multiple sclerosis.
    Stellmann JP; Young KL; Vettorazzi E; Pöttgen J; Heesen C
    Eur J Neurol; 2017 Jun; 24(6):851-857. PubMed ID: 28544407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alternative diagnoses in patients referred to specialized centers for suspected MS.
    Yamout BI; Khoury SJ; Ayyoubi N; Doumiati H; Fakhreddine M; Ahmed SF; Tamim H; Al-Hashel JY; Behbehani R; Alroughani R
    Mult Scler Relat Disord; 2017 Nov; 18():85-89. PubMed ID: 29141828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving MS patient care.
    Rieckmann P
    J Neurol; 2004 Sep; 251 Suppl 5():v69-v73. PubMed ID: 15549359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple sclerosis and mobility restriction.
    Baum HM; Rothschild BB
    Arch Phys Med Rehabil; 1983 Dec; 64(12):591-6. PubMed ID: 6661022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of the cooling suit method applied to individuals with multiple sclerosis on fatigue and activities of daily living.
    Özkan Tuncay F; Mollaoğlu M
    J Clin Nurs; 2017 Dec; 26(23-24):4527-4536. PubMed ID: 28252819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of misdiagnosis of multiple sclerosis.
    Levin N; Mor M; Ben-Hur T
    Isr Med Assoc J; 2003 Jul; 5(7):489-90. PubMed ID: 12901244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transdermal application of myelin peptides in multiple sclerosis treatment.
    Walczak A; Siger M; Ciach A; Szczepanik M; Selmaj K
    JAMA Neurol; 2013 Sep; 70(9):1105-9. PubMed ID: 23817921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait.
    Alroughani R; Ashkanani A; Al-Hashel J; Khan R; Thussu A; Alexander KJ; Vembu P; Sharfuddin K; Lamdhade S; John JK; Alkhashan S; Abualmelh M; Al-Shammri S
    Clin Neurol Neurosurg; 2016 Apr; 143():51-64. PubMed ID: 26896783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.